78070532 - PAION

Information

• Trademark
• 78070532

• Source

• Serial Number

  78070532

• Registration Number

  3134824

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 35 - Advertising
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  June 22, 2001
  23 years ago

• Registration Date

  August 29, 2006
  18 years ago

• Transaction Date

  May 16, 2017
  7 years ago

• Status Date

  April 07, 2017
  7 years ago

• Published for Opposition Date

  June 06, 2006
  18 years ago

• Location Date

  March 14, 2013
  11 years ago

• First Use Anywhere Date

  February 01, 2005
  19 years ago

• First Use In Commerce Date

  February 01, 2005
  19 years ago

• Status Code

  710

• Employee Name

  WEBSTER, WILLIAM M

• Attorney Docket Number

  S5775

  Attorney Name

  Gary D. Krugman

  Law Office Assigned Location Code

  L20

• Owners

  • Paion Company, Limited

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• GS0011: (Based on 44(e)) Reagents for scientific or medical research use; diagnostic preparations or reagents for scientific or research use, biochemical reagents for scientific or medical research use; biochemical diagnostic preparations or reagents for scientific or research use
• GS0051: (Based on 44(e)) Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment [ and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, ] nervous diseases, [ diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents; ] medical and clinical diagnostic reagents for clinical or medical laboratory use
• GS0101: [ (Based on 44(e)) Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting medical diagnostic tests and blood specimen analysis of the human blood clotting system; medical devices, namely, coated catheters, medical stents, surgical implants comprising artificial materials; membranes intended for medical use, namely, filters for dialysis, hemofiltration ]
• GS0351: [ (Based on 44(e)) Computerized database management, namely, editing, evaluating and processing data for third parties ]
• GS0411: [ (Based on Use in Commerce) Educational services, namely, providing seminars, informational events and/or workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, gendiagnostics ]
• GS0421: (Based on 44(e)) [ Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, providing pharmaceutical advice to others regarding governmental regulatory laws and practices, performing pre-clinical studies, quality control; ] preparation of expert opinions in the field of [ chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry, ] product research and development of medical devices and pharmaceutical preparations; [ and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries; ] performance of pre-clinical studies, namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products; [ bio-chemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment; ] scientific research on and development of [ medical diagnostic equipment and ] pharmaceutical preparations and products for the treatment of [ tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, ] nervous diseases, [ diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, ] pain [ and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment ]
• TR0010: The English translation of the Greek word PAION in the mark is the name of a Greek mythological god.

Case File Event Statements

• 4/7/2017 - 7 years ago

  62 - CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 Type: CAEX

• 8/29/2015 - 9 years ago

  61 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2

• 3/14/2013 - 11 years ago

  60 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85

• 3/14/2013 - 11 years ago

  59 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P

• 2/27/2013 - 11 years ago

  58 - REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Type: 815F

• 3/14/2013 - 11 years ago

  57 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 2/27/2013 - 11 years ago

  56 - TEAS SECTION 8 & 15 RECEIVED Type: E815

• 11/15/2006 - 17 years ago

  55 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 8/29/2006 - 18 years ago

  54 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/6/2006 - 18 years ago

  53 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/17/2006 - 18 years ago

  52 - NOTICE OF PUBLICATION Type: NPUB

• 4/14/2006 - 18 years ago

  51 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 4/7/2006 - 18 years ago

  50 - ASSIGNED TO LIE Type: ALIE

• 4/6/2006 - 18 years ago

  49 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/6/2006 - 18 years ago

  48 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 4/6/2006 - 18 years ago

  47 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/6/2006 - 18 years ago

  46 - USE AMENDMENT ACCEPTED Type: IUAA

• 3/28/2006 - 18 years ago

  45 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 3/14/2006 - 18 years ago

  44 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/28/2006 - 18 years ago

  43 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 3/9/2006 - 18 years ago

  42 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/28/2006 - 18 years ago

  41 - AMENDMENT TO USE PROCESSING COMPLETE Type: AUPC

• 3/14/2006 - 18 years ago

  40 - USE AMENDMENT FILED Type: IUAF

• 3/14/2006 - 18 years ago

  39 - PAPER RECEIVED Type: MAIL

• 3/9/2006 - 18 years ago

  38 - PAPER RECEIVED Type: MAIL

• 1/30/2006 - 18 years ago

  37 - NON-FINAL ACTION MAILED Type: CNRT

• 1/30/2006 - 18 years ago

  36 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/30/2006 - 18 years ago

  35 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 1/24/2006 - 18 years ago

  34 - 1(B) BASIS DELETED; NEW BASIS REQUESTED Type: ADBS

• 1/24/2006 - 18 years ago

  33 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN

• 12/22/2005 - 18 years ago

  32 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG

• 11/18/2005 - 18 years ago

  31 - PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED Type: PDCB

• 11/18/2005 - 18 years ago

  30 - PAPER RECEIVED Type: MAIL

• 9/15/2005 - 19 years ago

  29 - EXTENSION 5 GRANTED Type: EX5G

• 9/1/2005 - 19 years ago

  28 - EXTENSION 5 FILED Type: EXT5

• 9/1/2005 - 19 years ago

  27 - PAPER RECEIVED Type: MAIL

• 4/18/2005 - 19 years ago

  26 - EXTENSION 4 GRANTED Type: EX4G

• 3/9/2005 - 19 years ago

  25 - EXTENSION 4 FILED Type: EXT4

• 3/9/2005 - 19 years ago

  24 - PAPER RECEIVED Type: MAIL

• 9/28/2004 - 20 years ago

  23 - EXTENSION 3 GRANTED Type: EX3G

• 9/8/2004 - 20 years ago

  22 - EXTENSION 3 FILED Type: EXT3

• 9/8/2004 - 20 years ago

  21 - PAPER RECEIVED Type: MAIL

• 8/11/2004 - 20 years ago

  20 - CASE FILE IN TICRS Type: CFIT

• 3/23/2004 - 20 years ago

  19 - EXTENSION 2 GRANTED Type: EX2G

• 3/8/2004 - 20 years ago

  18 - EXTENSION 2 FILED Type: EXT2

• 3/8/2004 - 20 years ago

  17 - PAPER RECEIVED Type: MAIL

• 10/8/2003 - 21 years ago

  16 - EXTENSION 1 GRANTED Type: EX1G

• 9/9/2003 - 21 years ago

  15 - EXTENSION 1 FILED Type: EXT1

• 10/8/2003 - 21 years ago

  14 - DIVISIONAL PROCESSING COMPLETE Type: DPCC

• 9/9/2003 - 21 years ago

  13 - DIVISIONAL REQUEST RECEIVED Type: DRRR

• 9/9/2003 - 21 years ago

  12 - PAPER RECEIVED Type: MAIL

• 3/11/2003 - 21 years ago

  11 - NOA MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 12/17/2002 - 21 years ago

  10 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/27/2002 - 21 years ago

  9 - NOTICE OF PUBLICATION Type: NPUB

• 10/15/2002 - 22 years ago

  8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/1/2002 - 22 years ago

  7 - ASSIGNED TO EXAMINER Type: DOCK

• 8/22/2002 - 22 years ago

  6 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/22/2002 - 22 years ago

  5 - PAPER RECEIVED Type: MAIL

• 5/9/2002 - 22 years ago

  4 - FINAL REFUSAL MAILED Type: CNFR

• 11/19/2001 - 22 years ago

  3 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/17/2001 - 23 years ago

  2 - NON-FINAL ACTION MAILED Type: CNRT

• 8/24/2001 - 23 years ago

  1 - ASSIGNED TO EXAMINER Type: DOCK